IBDEI0AA ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13652,1,2,0)
 ;;=2^LYMPHOMA,MARGINAL ZONE
 ;;^UTILITY(U,$J,358.3,13652,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,13653,0)
 ;;=200.50^^91^807^33
 ;;^UTILITY(U,$J,358.3,13653,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13653,1,1,0)
 ;;=1^200.50
 ;;^UTILITY(U,$J,358.3,13653,1,2,0)
 ;;=2^LYMPHOMA,PRIM CTR NERVOUS SYS
 ;;^UTILITY(U,$J,358.3,13653,2)
 ;;=^335298
 ;;^UTILITY(U,$J,358.3,13654,0)
 ;;=202.90^^91^807^32
 ;;^UTILITY(U,$J,358.3,13654,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13654,1,1,0)
 ;;=1^202.90
 ;;^UTILITY(U,$J,358.3,13654,1,2,0)
 ;;=2^LYMPHOMA,OTHER SITE
 ;;^UTILITY(U,$J,358.3,13654,2)
 ;;=^267504
 ;;^UTILITY(U,$J,358.3,13655,0)
 ;;=200.10^^91^807^34
 ;;^UTILITY(U,$J,358.3,13655,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13655,1,1,0)
 ;;=1^200.10
 ;;^UTILITY(U,$J,358.3,13655,1,2,0)
 ;;=2^LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,13655,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,13656,0)
 ;;=172.9^^91^807^35
 ;;^UTILITY(U,$J,358.3,13656,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13656,1,1,0)
 ;;=1^172.9
 ;;^UTILITY(U,$J,358.3,13656,1,2,0)
 ;;=2^MALIGNANT MELANOMA
 ;;^UTILITY(U,$J,358.3,13656,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,13657,0)
 ;;=199.0^^91^807^37
 ;;^UTILITY(U,$J,358.3,13657,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13657,1,1,0)
 ;;=1^199.0
 ;;^UTILITY(U,$J,358.3,13657,1,2,0)
 ;;=2^METASTATIC CA OF UNKN PRIMARY
 ;;^UTILITY(U,$J,358.3,13657,2)
 ;;=^267340
 ;;^UTILITY(U,$J,358.3,13658,0)
 ;;=203.00^^91^807^38
 ;;^UTILITY(U,$J,358.3,13658,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13658,1,1,0)
 ;;=1^203.00
 ;;^UTILITY(U,$J,358.3,13658,1,2,0)
 ;;=2^MULTIPLE MYELOMA
 ;;^UTILITY(U,$J,358.3,13658,2)
 ;;=^336847
 ;;^UTILITY(U,$J,358.3,13659,0)
 ;;=238.75^^91^807^39
 ;;^UTILITY(U,$J,358.3,13659,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13659,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,13659,1,2,0)
 ;;=2^MYELODYSPLASTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,13659,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,13660,0)
 ;;=157.9^^91^807^41
 ;;^UTILITY(U,$J,358.3,13660,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13660,1,1,0)
 ;;=1^157.9
 ;;^UTILITY(U,$J,358.3,13660,1,2,0)
 ;;=2^PANCREATIC CANCER
 ;;^UTILITY(U,$J,358.3,13660,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,13661,0)
 ;;=187.9^^91^807^42
 ;;^UTILITY(U,$J,358.3,13661,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13661,1,1,0)
 ;;=1^187.9
 ;;^UTILITY(U,$J,358.3,13661,1,2,0)
 ;;=2^PENILE CANCER
 ;;^UTILITY(U,$J,358.3,13661,2)
 ;;=^267252
 ;;^UTILITY(U,$J,358.3,13662,0)
 ;;=163.9^^91^807^44
 ;;^UTILITY(U,$J,358.3,13662,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13662,1,1,0)
 ;;=1^163.9
 ;;^UTILITY(U,$J,358.3,13662,1,2,0)
 ;;=2^PLEURAL CANCER
 ;;^UTILITY(U,$J,358.3,13662,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,13663,0)
 ;;=185.^^91^807^45
 ;;^UTILITY(U,$J,358.3,13663,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13663,1,1,0)
 ;;=1^185.
 ;;^UTILITY(U,$J,358.3,13663,1,2,0)
 ;;=2^PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,13663,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,13664,0)
 ;;=287.9^^91^807^46
 ;;^UTILITY(U,$J,358.3,13664,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13664,1,1,0)
 ;;=1^287.9
 ;;^UTILITY(U,$J,358.3,13664,1,2,0)
 ;;=2^PURPURA/OTH HEMORRHAGIC COND
 ;;^UTILITY(U,$J,358.3,13664,2)
 ;;=^123920
 ;;^UTILITY(U,$J,358.3,13665,0)
 ;;=154.3^^91^807^47
 ;;^UTILITY(U,$J,358.3,13665,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13665,1,1,0)
 ;;=1^154.3
 ;;^UTILITY(U,$J,358.3,13665,1,2,0)
 ;;=2^RECTAL CANCER
 ;;^UTILITY(U,$J,358.3,13665,2)
 ;;=^267092
 ;;^UTILITY(U,$J,358.3,13666,0)
 ;;=189.9^^91^807^62
 ;;^UTILITY(U,$J,358.3,13666,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13666,1,1,0)
 ;;=1^189.9
 ;;^UTILITY(U,$J,358.3,13666,1,2,0)
 ;;=2^URINARY ORGAN CANCER
 ;;^UTILITY(U,$J,358.3,13666,2)
 ;;=^267269
 ;;^UTILITY(U,$J,358.3,13667,0)
 ;;=142.9^^91^807^49
 ;;^UTILITY(U,$J,358.3,13667,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13667,1,1,0)
 ;;=1^142.9
 ;;^UTILITY(U,$J,358.3,13667,1,2,0)
 ;;=2^SALIVARY GLAND CANCER
 ;;^UTILITY(U,$J,358.3,13667,2)
 ;;=^267009
 ;;^UTILITY(U,$J,358.3,13668,0)
 ;;=160.9^^91^807^52
 ;;^UTILITY(U,$J,358.3,13668,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13668,1,1,0)
 ;;=1^160.9
 ;;^UTILITY(U,$J,358.3,13668,1,2,0)
 ;;=2^SINUS,NASAL & MIDDLE EAR CANCER
 ;;^UTILITY(U,$J,358.3,13668,2)
 ;;=^267127
 ;;^UTILITY(U,$J,358.3,13669,0)
 ;;=151.9^^91^807^56
 ;;^UTILITY(U,$J,358.3,13669,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13669,1,1,0)
 ;;=1^151.9
 ;;^UTILITY(U,$J,358.3,13669,1,2,0)
 ;;=2^STOMACH CANCER
 ;;^UTILITY(U,$J,358.3,13669,2)
 ;;=^73532
 ;;^UTILITY(U,$J,358.3,13670,0)
 ;;=186.9^^91^807^57
 ;;^UTILITY(U,$J,358.3,13670,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13670,1,1,0)
 ;;=1^186.9
 ;;^UTILITY(U,$J,358.3,13670,1,2,0)
 ;;=2^TESTICULAR CANCER
 ;;^UTILITY(U,$J,358.3,13670,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,13671,0)
 ;;=164.9^^91^807^59
 ;;^UTILITY(U,$J,358.3,13671,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13671,1,1,0)
 ;;=1^164.9
 ;;^UTILITY(U,$J,358.3,13671,1,2,0)
 ;;=2^THYMUS,HRT & MEDIASTINAL CA
 ;;^UTILITY(U,$J,358.3,13671,2)
 ;;=^267150
 ;;^UTILITY(U,$J,358.3,13672,0)
 ;;=141.9^^91^807^61
 ;;^UTILITY(U,$J,358.3,13672,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13672,1,1,0)
 ;;=1^141.9
 ;;^UTILITY(U,$J,358.3,13672,1,2,0)
 ;;=2^TONGUE CANCER
 ;;^UTILITY(U,$J,358.3,13672,2)
 ;;=^266995
 ;;^UTILITY(U,$J,358.3,13673,0)
 ;;=239.9^^91^807^40
 ;;^UTILITY(U,$J,358.3,13673,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13673,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,13673,1,2,0)
 ;;=2^OTHER CANCER
 ;;^UTILITY(U,$J,358.3,13673,2)
 ;;=^82022
 ;;^UTILITY(U,$J,358.3,13674,0)
 ;;=154.2^^91^807^1
 ;;^UTILITY(U,$J,358.3,13674,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13674,1,1,0)
 ;;=1^154.2
 ;;^UTILITY(U,$J,358.3,13674,1,2,0)
 ;;=2^ANAL CANAL CANCER
 ;;^UTILITY(U,$J,358.3,13674,2)
 ;;=^267091
 ;;^UTILITY(U,$J,358.3,13675,0)
 ;;=154.3^^91^807^2
 ;;^UTILITY(U,$J,358.3,13675,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13675,1,1,0)
 ;;=1^154.3
 ;;^UTILITY(U,$J,358.3,13675,1,2,0)
 ;;=2^ANUS CANCER
 ;;^UTILITY(U,$J,358.3,13675,2)
 ;;=^267092
 ;;^UTILITY(U,$J,358.3,13676,0)
 ;;=164.0^^91^807^58
 ;;^UTILITY(U,$J,358.3,13676,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13676,1,1,0)
 ;;=1^164.0
 ;;^UTILITY(U,$J,358.3,13676,1,2,0)
 ;;=2^THYMUS CANCER
 ;;^UTILITY(U,$J,358.3,13676,2)
 ;;=^267145
 ;;^UTILITY(U,$J,358.3,13677,0)
 ;;=164.1^^91^807^18
 ;;^UTILITY(U,$J,358.3,13677,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13677,1,1,0)
 ;;=1^164.1
 ;;^UTILITY(U,$J,358.3,13677,1,2,0)
 ;;=2^HEART CANCER
 ;;^UTILITY(U,$J,358.3,13677,2)
 ;;=^267146
 ;;^UTILITY(U,$J,358.3,13678,0)
 ;;=164.2^^91^807^36
 ;;^UTILITY(U,$J,358.3,13678,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13678,1,1,0)
 ;;=1^164.2
 ;;^UTILITY(U,$J,358.3,13678,1,2,0)
 ;;=2^MEDIASTINAL CA
 ;;^UTILITY(U,$J,358.3,13678,2)
 ;;=^267147
 ;;^UTILITY(U,$J,358.3,13679,0)
 ;;=173.90^^91^807^53
 ;;^UTILITY(U,$J,358.3,13679,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13679,1,1,0)
 ;;=1^173.90
 ;;^UTILITY(U,$J,358.3,13679,1,2,0)
 ;;=2^SKIN, MALIGNANT SITE UNSP
 ;;^UTILITY(U,$J,358.3,13679,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,13680,0)
 ;;=173.91^^91^807^4
 ;;^UTILITY(U,$J,358.3,13680,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13680,1,1,0)
 ;;=1^173.91
 ;;^UTILITY(U,$J,358.3,13680,1,2,0)
 ;;=2^BCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,13680,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,13681,0)
 ;;=173.92^^91^807^51
 ;;^UTILITY(U,$J,358.3,13681,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13681,1,1,0)
 ;;=1^173.92
 ;;^UTILITY(U,$J,358.3,13681,1,2,0)
 ;;=2^SCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,13681,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,13682,0)
 ;;=173.99^^91^807^54
 ;;^UTILITY(U,$J,358.3,13682,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13682,1,1,0)
 ;;=1^173.99
 ;;^UTILITY(U,$J,358.3,13682,1,2,0)
 ;;=2^SKIN, MALIGNANT SITE UNSP
 ;;^UTILITY(U,$J,358.3,13682,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,13683,0)
 ;;=174.9^^91^807^8
 ;;^UTILITY(U,$J,358.3,13683,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13683,1,1,0)
 ;;=1^174.9
 ;;^UTILITY(U,$J,358.3,13683,1,2,0)
 ;;=2^BREAST CANCER-FEMALE
 ;;^UTILITY(U,$J,358.3,13683,2)
 ;;=^267202
 ;;^UTILITY(U,$J,358.3,13684,0)
 ;;=189.0^^91^807^48
 ;;^UTILITY(U,$J,358.3,13684,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13684,1,1,0)
 ;;=1^189.0
 ;;^UTILITY(U,$J,358.3,13684,1,2,0)
 ;;=2^RENAL CELL CANCER
 ;;^UTILITY(U,$J,358.3,13684,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,13685,0)
 ;;=149.0^^91^807^43
 ;;^UTILITY(U,$J,358.3,13685,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13685,1,1,0)
 ;;=1^149.0
 ;;^UTILITY(U,$J,358.3,13685,1,2,0)
 ;;=2^PHARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,13685,2)
 ;;=^267051
 ;;^UTILITY(U,$J,358.3,13686,0)
 ;;=V66.7^^91^808^1
 ;;^UTILITY(U,$J,358.3,13686,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13686,1,1,0)
 ;;=1^V66.7
 ;;^UTILITY(U,$J,358.3,13686,1,2,0)
 ;;=2^Hospice/Palliative Care-USE w/ ea encounter
 ;;^UTILITY(U,$J,358.3,13686,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,13687,0)
 ;;=348.1^^91^809^1
 ;;^UTILITY(U,$J,358.3,13687,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13687,1,1,0)
 ;;=1^348.1
 ;;^UTILITY(U,$J,358.3,13687,1,2,0)
 ;;=2^ANOXIC BRAIN DAMAGE
 ;;^UTILITY(U,$J,358.3,13687,2)
 ;;=^7979
 ;;^UTILITY(U,$J,358.3,13688,0)
 ;;=348.5^^91^809^2
 ;;^UTILITY(U,$J,358.3,13688,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13688,1,1,0)
 ;;=1^348.5
 ;;^UTILITY(U,$J,358.3,13688,1,2,0)
 ;;=2^CEREBRAL EDEMA
 ;;^UTILITY(U,$J,358.3,13688,2)
 ;;=^16710
 ;;^UTILITY(U,$J,358.3,13689,0)
 ;;=348.4^^91^809^3
 ;;^UTILITY(U,$J,358.3,13689,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13689,1,1,0)
 ;;=1^348.4
 ;;^UTILITY(U,$J,358.3,13689,1,2,0)
 ;;=2^COMPRESSION OF BRAIN
 ;;^UTILITY(U,$J,358.3,13689,2)
 ;;=^27114
 ;;^UTILITY(U,$J,358.3,13690,0)
 ;;=291.1^^91^809^7
 ;;^UTILITY(U,$J,358.3,13690,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13690,1,1,0)
 ;;=1^291.1
